SELLAS Life Sciences Group, Inc. (SLS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for SELLAS Life Sciences Group, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -15.30x | -2.06x | -0.79x | -1.11x | -4.14x | -2.75x |
| P/B Ratio | 5.80x | 6.72x | -3.69x | 9.44x | 4.21x | 1.65x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 45.77x | 11.26x | 24.28x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 90.0% | 97.4% | 100.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | -4195.0% | -332.8% | -893.8% |
| Net Margin | 0.0% | 0.0% | 0.0% | -4130.1% | -272.4% | -881.9% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | -3149.3% | -241.1% | -863.0% |
| Liquidity | ||||||
| Current Ratio | 10.72x | 1.72x | 0.23x | 1.14x | 4.63x | 2.99x |
| Quick Ratio | 10.72x | 1.72x | 0.23x | 1.14x | 4.63x | 2.99x |
| Leverage | ||||||
| Debt/Equity | 0.01x | 0.11x | -0.11x | 0.19x | 0.04x | 0.04x |
YoY = year-over-year change. Source: FMP..